About Us
Mission
Members
Board of Directors
Staff
Annual Meeting
Economic Impact
Issues
PAMA
Economic Impact of Clinical Labs
Protecting Access to Medicare Act
Laboratory Developed Tests
Reimbursement and Coverage
Patient Access to Lab Services
Value of Labs
IOAS Exception and Self-Referral
Regulatory Issues
Value of Health IT Data Standards
TRICARE Non-Coverage of LDTs
Take Action
News
ACLA Blog
ACLA Press Releases
Comments and Letters
ACLA In The News
Resources
CPT Committee
NGS NCD Work Group
Prior Authorization Work Group
Join Us
Home
Contact Us
Home
Contact Us
About Us
Mission
Members
Board of Directors
Staff
Annual Meeting
Economic Impact
Issues
PAMA
Economic Impact of Clinical Labs
Protecting Access to Medicare Act
Laboratory Developed Tests
Reimbursement and Coverage
Patient Access to Lab Services
Value of Labs
IOAS Exception and Self-Referral
Regulatory Issues
Value of Health IT Data Standards
TRICARE Non-Coverage of LDTs
Take Action
News
ACLA Blog
ACLA Press Releases
Comments and Letters
ACLA In The News
Resources
CPT Committee
NGS NCD Work Group
Prior Authorization Work Group
Join Us
Comments and Letters
ACLA Comments to House Energy & Commerce Committee regarding draft legislative proposal to reform diagnostic oversight
June 22, 2015
Categories:
Comments and Letters
,
Issues
,
Laboratory Developed Tests
,
News
Download (PDF, 370KB)
Print page / Save as PDF
